Is It Too Late to Buy SpaceX Stock?

SpaceX generated $18.7 billion of revenue in 2025, up 33% year over year, but the stock is valued at about $2.5 trillion, or roughly 130x trailing revenue. The article argues that while Starlink/connectivity drove more than half of revenue and most profits, the space unit grew only 8% and xAI lost money, making the valuation hard to justify on current fundamentals. The author is cautious on the shares, preferring to wait for a better entry point despite long-term upside.

Analysis

The market is not just pricing a growth story; it is pricing a regime change where one company’s infrastructure layer becomes a quasi-utility with optionality in connectivity, launch, and AI adjacency. That makes near-term valuation optics less relevant than the durability of cash generation from the most mature segment, but it also creates a fragility problem: once the “future platform” narrative is doing most of the work, any slowdown in subscriber adds or launch cadence can compress multiple turns quickly. In other words, this is a sentiment-driven asset with a long-duration cash-flow base, not a pure fundamentals compounder.

The second-order winner is not necessarily the broad megacap complex, but adjacent beneficiaries of capital reallocation. If investors rotate out of stretched moonshots and back into proven AI/infrastructure cash generators, the clearest beneficiaries are MSFT, NVDA, AVGO, and TSM, which have both stronger earnings visibility and lower narrative dispersion. The loser is TSLA on a relative basis: the same “future technology” framing now has a higher hurdle rate because investors can more easily compare two Elon-linked optionality trades and choose the one with a clearer monetization path.

Catalyst risk cuts both ways. In the next 1-3 months, the stock is vulnerable to any sign that growth in the core connectivity franchise decelerates from hypergrowth toward mere strong growth, because the market is implicitly underwriting a decade of near-perfect execution. Over a 12-24 month horizon, however, even modest re-rating is hard to fade if the company can keep converting free cash flow into a larger addressable market; the path dependency matters more than the current revenue base. Consensus seems to be missing that this is less about whether the valuation is “right” today and more about whether public-market liquidity allows the multiple to stay detached long enough for the business to catch up.

Key Decisions for Investors

• Fade the name tactically: initiate a small short or buy puts on SPCX on strength, targeting a 4-8 week horizon; risk/reward favors downside if post-IPO enthusiasm normalizes and multiple compression starts before fundamentals can re-rate.
• Pair trade: long MSFT/NVDA basket vs short SPCX for the next 1-3 months; this isolates AI/infrastructure exposure while hedging broad tech beta and captures relative valuation mean reversion.
• Use TSLA as the cleaner optionality substitute: if the goal is long-duration Elon exposure, prefer TSLA over SPCX on a 6-12 month view because the public float is deeper and the catalyst set is easier to underwrite.
• For long-only portfolios, avoid initiating a full-size position here; if compelled, cap sizing at a 0.5-1.0% starter position and add only on a 20-30% drawdown or after two quarters of evidence that segment mix is broadening beyond connectivity.